文献速递药物不良反应与药物警戒

2001至2019年全球药物不良事件相关死亡率趋势:54国分析

International Trends in Adverse Drug Event-Related Mortality from 2001 to 2019: An Analysis of the World Health Organization Mortality Database from 54 Countries.
PubMed 文献 · Drug Saf · 2023-12-22

本研究基于世界卫生组织死亡数据库,分析54个国家2001至2019年药物不良事件相关死亡率趋势。全球年龄标化死亡率从2001年每10万人2.05升至2019年6.86,增长约3.3倍;男性高于女性,≥75岁人群更高,北美在五个区域中最高。建立药物警戒系统有助于降低全球药物不良事件相关死亡率。

要点

  • 全球ADE相关死亡率从2001年2.05/10万升至2019年6.86/10万,增长约3.3倍。
  • 男性ADE相关死亡率高于女性,尤其20-50岁人群。
  • ≥75岁人群ADE相关死亡率高于年轻人群,北美在五个区域中最高。

核心结论

  • 全球药物不良事件相关死亡率从2001年至2019年呈上升趋势,负担增加。

研究设计与样本

  • 观察性研究分析世界卫生组织死亡数据库2001至2019年54个国家ADE相关死亡率长期趋势。

主要发现

  • 全球ADE相关死亡率从2001年每10万人2.05(95%CI 0.92-3.18)升至2019年6.86(95%CI 5.76-7.95)。
  • 男性ADE相关死亡率高于女性,尤其20-50岁人群。
  • ≥75岁人群ADE相关死亡率高于年轻人群。
  • 北美在五个区域中ADE相关死亡率最高。
  • 2001至2019年全球ADE相关死亡率增长约3.3倍。

临床怎么用

  • 建立药物警戒系统可促进全球降低ADE相关死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Adverse drug events (ADEs) are becoming a significant public health issue. However, reports on ADE-related mortality are limited to national-level evaluations. Therefore, we aimed to reveal overall trends in ADE-related mortality across the 21st century on an international level. METHODS: This observational study analysed long-term trends in ADE-related mortality rates from 2001 to 2019 using the World Health Organization Mortality Database. The rates were analysed according to sex, age and region. North America, Latin America and the Caribbean, Western Europe, Eastern Europe and Western Pacific regions were assessed. Fifty-four countries were included with four-character International Statistical Classification of Disease and Related Health Problems, Tenth Revision codes in the database, population data in the World Population Prospects 2019 report, mortality data in more than half of the study period, and high-quality or medium-quality death registration data. A locally weighted regression curve was used to show international trends in age-standardised rates. RESULTS: The global ADE-related mortality rate per 100,000 population increased from 2.05 (95% confidence interval 0.92-3.18) in 2001 to 6.86 (95% confidence interval 5.76-7.95) in 2019. Mortality rates were higher among men than among women, especially in those aged 20-50 years. The population aged ≥ 75 years had higher ADE-related mortality rates than the younger population. North America had the highest mortality rate among the five regions. The global ADE-related mortality rate increased by approximately 3.3-fold from 2001 to 2019. CONCLUSIONS: The burden of ADEs has increased internationally with rising mortality rates. Establishing pharmacovigilance systems can facilitate efforts to reduce ADE-related mortality rates globally.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Koyama T, Iinuma S, Yamamoto M, et al. International Trends in Adverse Drug Event-Related Mortality from 2001 to 2019: An Analysis of the World Health Organization Mortality Database from 54 Countries. Drug Saf. 2023. PMID: 38133735. doi:10.1007/s40264-023-01387-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。